AI agents struggle with modern, content heavy websites. It's slow and expensive to crawl. The markdown standard makes your ...

Google today added Gemini AI to Google Maps, enabling a new Ask Maps feature. Gemini in maps can answer complex, real-world questions that Google says "a map could never answer before." There is a new ...

BUFFALO, N.Y. (WIVB) — News 4 celebrates Women’s History Month by recognizing remarkable women in Western New York. In 2026, we’re honoring a woman who raises money for cancer research in remembrance ...

TOPEKA, Kan. — Kansas lawmakers are moving forward with legislation they said is the final piece needed to protect the state as discussions continue around a potential new stadium for the Kansas City ...

WINDSOR LOCKS, Conn. (WWLP) – A partial government shutdown and the ongoing war in Iran are creating significant challenges for spring break travelers as the popular vacation period begins. The ...

Beirut, Lebanon – In the past week, the Israeli military has created a mass displacement crisis, killed around 400 people, rained bombs down across Lebanon, including the capital Beirut, and pushed ...

TAMPA, Fla. (WFLA) — Friday is the start of the Paralympic Games in Italy. Students at the University of South Florida are developing new devices to help para-athletes compete. Their work is geared ...

WICHITA, Kan. (KSNW) — A bridge reconstruction project on U.S. Highway 160 in south-central Kansas will create a 60-mile detour. Starting March 16, crews will begin reconstruction of the bridge over ...

Merck & Co. is splitting its main pharmaceutical unit in two in an effort to better highlight the parts of the business that are growing, as it stares down a patent cliff for its best-selling cancer ...

Merck said on Monday it would split its business into two, creating ⁠a distinct division for its cancer franchise led by blockbuster drug Keytruda while grouping its non-oncology treatments separately ...

Feb 23 (Reuters) - Merck said on ⁠Monday ⁠it would create a separate ⁠division for its cancer business, anchored by its top-selling drug Keytruda, as the U.S. drugmaker braces for the upcoming patent ...

Feb 23 (Reuters) - Merck is splitting its human-health business into two ‌divisions to offset pressures ‌related to the loss of patent for its top-selling drug Keytruda, the Wall Street Journal ...